- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03723733
Compensatory Brain Mechanisms for Amygdala-associated Cognitive Dysfunction: Potential Role of the Cortical Mirror Neuron System
October 26, 2018 updated by: Keith Kendrick, University of Electronic Science and Technology of China
Identify if the mirror neuron system, or other networks, can compensate for amygdala dysfunction, using behavior and structural/functional MRI.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
In the present study, investigators aim to investigate amygdala dysfunction & potential compensation in individuals with high and low traits (e.g.
Autism, Anxiety, Depression traits, Alexithymia), high and low stress or protective factors in the environment (social network, early life stress) and different molecular genetic make-up.
On the neural level, functional and structural connectivity as well as task-related BOLD activation will be assessed.
Study Type
Observational
Enrollment (Anticipated)
350
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 611731
- Recruiting
- China, Sichuan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years to 30 years (ADULT, CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
sutduents from University of Electronic Science and Technology of China
Description
Inclusion Criteria:
- Healthy subjects
Exclusion Criteria:
- history of head injury
- claustrophobia;
- medical or psychiatric illness
- female subjects were pregnant or taking oral contraceptives.
- taking any form of medication and drunk any caffeine-containing beverages on the day of the experiment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
brain activity and connectivity during social and cognitive tasks
Time Frame: 2 hours
|
brain activity and connectivity was measured by the fMRI scanner
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2016
Primary Completion (ANTICIPATED)
September 1, 2019
Study Completion (ANTICIPATED)
December 1, 2019
Study Registration Dates
First Submitted
October 26, 2018
First Submitted That Met QC Criteria
October 26, 2018
First Posted (ACTUAL)
October 29, 2018
Study Record Updates
Last Update Posted (ACTUAL)
October 29, 2018
Last Update Submitted That Met QC Criteria
October 26, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- UESTC-neuSCAN-28
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.